---
title: "Regenxbio Shares Fall After Downgrade From Goldman Sachs"
date: "2025-02-12 03:38:46"
summary: "Regenxbio  shares were down 7.5% in recent Tuesday trading after Goldman Sachs downgraded the stock to neutral from buy, and trimmed the price target to $14 from $38. Trading volume stood at roughly 661,000 shares, compared with the daily average of more than 1.3 million shares."
categories:
  - "MT Newswires"
lang:
  - "en"
translations:
  - "en"
tags:
  - "MT Newswires"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

Regenxbio shares were down 7.5% in recent Tuesday trading after Goldman Sachs downgraded the stock to neutral from buy, and trimmed the price target to $14 from $38.

Trading volume stood at roughly 661,000 shares, compared with the daily average of more than 1.3 million shares.

[MT Newswires](https://www.tradingview.com/news/mtnewswires.com:20250211:A3314789:0/)
